Jefferies Financial Group reaffirmed their hold rating on shares of Indivior (LON:INDV) in a report published on Tuesday morning, ThisIsMoney.Co.Uk reports.

INDV opened at GBX 83 ($1.02) on Tuesday. The firm has a market cap of $607.92 million and a price-to-earnings ratio of -6.38. The company has a current ratio of 1.75, a quick ratio of 1.64 and a debt-to-equity ratio of 730.77. Indivior has a 12 month low of GBX 32.90 ($0.40) and a 12 month high of GBX 89.16 ($1.10). The stock has a fifty day moving average price of GBX 64.08 and a 200-day moving average price of GBX 48.07.

About Indivior

Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence. The company's product pipeline focuses on treating opioid use disorder, alcohol use disorder, opiate overdose, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy analgesic products that include Temgesic, Burpex, and Buprenex.

Read More: What is dividend yield?

Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.